The Molecular Basis for Perforin Oligomerization and Transmembrane Pore Assembly
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Calreticulin—Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance As a Prognostic Biomarker in Ovarian
cells Review Calreticulin—Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients Michal Kielbik *, Izabela Szulc-Kielbik and Magdalena Klink Institute of Medical Biology, Polish Academy of Sciences, 106 Lodowa Str., 93-232 Lodz, Poland; [email protected] (I.S.-K.); [email protected] (M.K.) * Correspondence: [email protected]; Tel.: +48-42-27-23-636 Abstract: Immunogenic cell death (ICD) is a type of death, which has the hallmarks of necroptosis and apoptosis, and is best characterized in malignant diseases. Chemotherapeutics, radiotherapy and photodynamic therapy induce intracellular stress response pathways in tumor cells, leading to a secretion of various factors belonging to a family of damage-associated molecular patterns molecules, capable of inducing the adaptive immune response. One of them is calreticulin (CRT), an endoplasmic reticulum-associated chaperone. Its presence on the surface of dying tumor cells serves as an “eat me” signal for antigen presenting cells (APC). Engulfment of tumor cells by APCs results in the presentation of tumor’s antigens to cytotoxic T-cells and production of cytokines/chemokines, which activate immune cells responsible for tumor cells killing. Thus, the development of ICD and the expression of CRT can help standard therapy to eradicate tumor cells. Here, we review the physiological functions of CRT and its involvement in the ICD appearance in malignant dis- ease. Moreover, we also focus on the ability of various anti-cancer drugs to induce expression of surface CRT on ovarian cancer cells. The second aim of this work is to discuss and summarize the prognostic/predictive value of CRT in ovarian cancer patients. -
Role of Perforin-2 in Regulating Type I Interferon Signaling
https://www.scientificarchives.com/journal/journal-of-cellular-immunology Journal of Cellular Immunology Review Article Role of Perforin-2 in Regulating Type I Interferon Signaling Gregory V Plano, Noula Shembade* Department of Microbiology and Immunology, Sylvester Comprehensive Cancer Center Miller School of Medicine, University of Miami, Miami, FL 33136, USA *Correspondence should be addressed to Noula Shembade; [email protected] Received date: November 21, 2020, Accepted date: February 02, 2021 Copyright: © 2021 Plano G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Sepsis is a systemic inflammatory response caused by a harmful host immune reaction that is activated in response to microbial infections. Infection-induced type I interferons (IFNs) play critical roles during septic shock. Type I IFNs initiate their biological effects by binding to their transmembrane interferon receptors and initiating the phosphorylation and activation of tyrosine kinases TYK2 and JAK1, which promote phosphorylation and activation of STAT molecules. Type I IFN-induced activation of JAK/STAT pathways is a complex process and not well understood. Improper regulation of type I IFN responses can lead to the development of infectious and inflammation-related diseases, including septic shock, autoimmune diseases, and inflammatory syndromes. This review is mainly focused on the possible mechanistic roles of the transmembrane Perforin-2 molecule in the regulation of type I IFN- induced signaling. Keywords: JAK/STAT, Interferons, TYK2, STATs, Perforin-2, IFNAR1, IFNAR2 and Signaling Introduction and activator of transcription 2), respectively, under normal physiological conditions [4,5]. -
Apoptosis by Incomplete Infection
rESEArcH HIGHLIGHtS Apoptosis by incomplete infection Constraining inflammation κ Infection with human immunodeficiency virus (HIV) is The transcription factor NF- B is a critical mediator of Toll-like recep- characterized by progressive apoptosis of CD4+ T cells, and tor (TLR) signaling in response to a range of activators. In Genes & although some of the molecular participants in this process are Development, Barish et al. provide genetic and genomic evidence that known, the precise details remain unclear. Greene and colleagues the transcription factor Bcl-6 broadly antagonizes the TLR–NF-κB in Cell report the unexpected finding that nonproductive infection network. Genome-wide expression analyses and chromatin-immuno- of CD4+ T cells can also result in apoptosis. The authors use a precipitation sequencing (ChIP-Seq) show that Bcl-6 is a basal- and human lymphoid aggregation culture system to recapitulate in lipopolysaccharide (LPS)-induced inhibitor of many inflammatory vitro the events of HIV infection in the lymph node. The addition modules in bone marrow–derived macrophages. Bcl-6 controls one of HIV to this culture system results in the apoptosis of not only third of the LPS-elicited transcriptome, and sites for Bcl-6 and the productively infected but also nonpermissive CD4+ cells. Apoptosis NF-κB subunit p65 are located together in a nucleosomal window of the latter requires fusion with HIV and the initiation but not (200 base pairs) in 25% of the gene network controlled by TLR–NF-κB. completion of viral reverse transcription. The accumulation Stimulation of TLR4 reciprocally diminishes or enhances the binding of of incomplete HIV reverse transcripts results in activation of Bcl-6 and p65 to enhancer regions at target genes encoding key inflam- caspase-1 and caspase-3 and release of the inflammatory cytokine matory molecules, such as IL-1 and various chemokines. -
Ostreolysin A/Pleurotolysin B and Equinatoxins: Structure, Function and Pathophysiological Effects of These Pore-Forming Proteins
Ostreolysin A/Pleurotolysin B and Equinatoxins: Structure, Function and Pathophysiological Effects of These Pore-Forming Proteins. Robert Frangež, Dušan Šuput, Jordi Molgó, Evelyne Benoit To cite this version: Robert Frangež, Dušan Šuput, Jordi Molgó, Evelyne Benoit. Ostreolysin A/Pleurotolysin B and Equinatoxins: Structure, Function and Pathophysiological Effects of These Pore-Forming Proteins.. Toxins, MDPI, 2017, 9 (4), 10.3390/toxins9040128. hal-01572247 HAL Id: hal-01572247 https://hal.archives-ouvertes.fr/hal-01572247 Submitted on 20 May 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. toxins Review Ostreolysin A/Pleurotolysin B and Equinatoxins: Structure, Function and Pathophysiological Effects of These Pore-Forming Proteins Robert Frangež 1, Dušan Šuput 2, Jordi Molgó 3 and Evelyne Benoit 3,* 1 Institute of Preclinical Sciences, Veterinary Faculty, University of Ljubljana; 1115-Ljubljana, Slovenia; [email protected] 2 Laboratory for Cell Physiology and Toxinology, Institute of Pathophysiology, School of Medicine, University of Ljubljana, P.O. Box 11, 1105-Ljubljana, Slovenia; [email protected] 3 DRF/Institut de Sciences de la Vie Frédéric Joliot/SIMOPRO, CEA de Saclay, and Institut des Neurosciences Paris-Saclay (Neuro-PSI), UMR 9197 CNRS/Université Paris-Sud, 91190 Gif-sur-Yvette, France; [email protected] * Correspondence: [email protected]; Tel.: +33-169-085-685 Academic Editor: Michel R. -
Response of Cellular Innate Immunity to Cnidarian Pore-Forming Toxins
Review Response of Cellular Innate Immunity to Cnidarian Pore-Forming Toxins Wei Yuen Yap 1 and Jung Shan Hwang 2,* 1 Department of Biological Sciences, School of Science and Technology, Sunway University, No. 5 Jalan Universiti, Bandar Sunway, Selangor Darul Ehsan 47500, Malaysia; [email protected] 2 Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, No. 5 Jalan Universiti, Bandar Sunway, Selangor Darul Ehsan 47500, Malaysia * Correspondence: [email protected]; Tel.: +603-7491-8622 (ext. 7414) Academic Editor: Jean-Marc Sabatier Received: 23 August 2018; Accepted: 28 September 2018; Published: 4 October 2018 Abstract: A group of stable, water-soluble and membrane-bound proteins constitute the pore forming toxins (PFTs) in cnidarians. They interact with membranes to physically alter the membrane structure and permeability, resulting in the formation of pores. These lesions on the plasma membrane causes an imbalance of cellular ionic gradients, resulting in swelling of the cell and eventually its rupture. Of all cnidarian PFTs, actinoporins are by far the best studied subgroup with established knowledge of their molecular structure and their mode of pore-forming action. However, the current view of necrotic action by actinoporins may not be the only mechanism that induces cell death since there is increasing evidence showing that pore-forming toxins can induce either necrosis or apoptosis in a cell-type, receptor and dose-dependent manner. In this review, we focus on the response of the cellular immune system to the cnidarian pore-forming toxins and the signaling pathways that might be involved in these cellular responses. -
Stonefish Toxin Defines an Ancient Branch of the Perforin-Like Superfamily
Stonefish toxin defines an ancient branch of the perforin-like superfamily Andrew M. Ellisdona,b, Cyril F. Reboula,b, Santosh Panjikara,c, Kitmun Huynha, Christine A. Oelliga, Kelly L. Wintera,d, Michelle A. Dunstonea,b,e, Wayne C. Hodgsond, Jamie Seymourf, Peter K. Deardeng, Rodney K. Twetenh, James C. Whisstocka,b,1,2, and Sheena McGowane,1,2 aBiomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia; bAustralian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Melbourne, VIC, 3800, Australia; cAustralian Synchrotron, Macromolecular Crystallography, Melbourne, VIC, 3168, Australia; dBiomedicine Discovery Institute and Department of Pharmacology, Monash University, Melbourne, VIC, 3800, Australia; eBiomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, VIC, 3800, Australia; fCentre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, QLD, 4870, Australia; gDepartment of Biochemistry and Genetics Otago, University of Otago, Dunedin, 9054 Aotearoa–New Zealand; and hDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104 Edited by Brenda A. Schulman, St. Jude Children’s Research Hospital, Memphis, TN, and approved November 3, 2015 (received for review April 19, 2015) The lethal factor in stonefish venom is stonustoxin (SNTX), a parallel interface along their entire 115-Å length (2,908 Å2 heterodimeric cytolytic protein that induces cardiovascular collapse buried surface area) (Fig. 1 A–D and Fig. S1). Fold recognition in humans and native predators. Here, using X-ray crystallography, searches reveal that each SNTX protein comprises four do- we make the unexpected finding that SNTX is a pore-forming mains (Fig. -
Measuring Kinetic Drivers of Pneumolysin Pore Structure
Eur Biophys J (2016) 45:365–376 DOI 10.1007/s00249-015-1106-x ORIGINAL ARTICLE Measuring kinetic drivers of pneumolysin pore structure Robert J. C. Gilbert1 · Andreas F.-P. Sonnen2 Received: 7 October 2015 / Revised: 1 December 2015 / Accepted: 7 December 2015 / Published online: 23 February 2016 © The Author(s) 2016. This article is published with open access at Springerlink.com Abstract Most membrane attack complex-perforin/ Keywords Pore formation · Kinetics · MACPF/CDC · cholesterol-dependent cytolysin (MACPF/CDC) proteins Toroidal pore · Oligomerization · Membrane structure are thought to form pores in target membranes by assem- bling into pre-pore oligomers before undergoing a pre-pore to pore transition. Assembly during pore formation is into Introduction both full rings of subunits and incomplete rings (arcs). The balance between arcs and full rings is determined by The membrane attack complex-perforin/cholesterol- a mechanism dependent on protein concentration in which dependent cytolysin (MACPF/CDC) family is the largest- arc pores arise due to kinetic trapping of the pre-pore forms known group of pore-forming proteins (Anderluh and by the depletion of free protein subunits during oligomeri- Gilbert 2014; Gilbert et al. 2013). Members have been zation. Here we describe the use of a kinetic assay to study identified in every kind of cellular life form apart from the pore formation in red blood cells by the MACPF/CDC Archaebacteria, and within their producing organisms they pneumolysin from Streptococcus pneumoniae. We show enact a plethora of different biological functions (Ander- that cell lysis displays two kinds of dependence on pro- luh et al. -
Mechanism of Mammalian Cell Lysis Mediated by Peptide Defensins
Mechanism of Mammalian Cell Lysis Mediated by Peptide Defensins Evidence for an Initial Alteration of the Plasma Membrane Alan Lichtenstein Division ofHematology/Oncology, Department ofMedicine, Veterans Administration Wadsworth-UCLA Medical Center, Los Angeles, California 90073 Abstract targets, are three small (mol wt 3,900) cationic peptides termed defensins or human neutrophil peptides 1, 2, and 3 (HNP Defensins induce ion channels in model lipid bilayers and per- 1-3).' The human defensins are secreted by activated PMNs meabilize the membranes of Escherichia coli. We investigated (10) and could, therefore, function as cytotoxins during anti- whether similar membrane-active events occur during defensin- body-dependent cellular cytotoxicity. In addition, a synergistic mediated cytolysis of tumor cells. Although defensin-treated cytotoxic effect occurs when target cells are exposed to a combi- K562 targets did not release chromium-labeled cytoplasmic nation of defensins and toxic oxidants (8). It is, thus, conceiv- components for 5-6 h, they experienced a rapid collapse able that defensins may play a role in tissue injury seen during (within minutes) of the membrane potential, efflux of rubidium, inflammatory or infectious processes. and influx of trypan blue. Defensin treatment also blunted the To investigate the mechanism of defensin-induced injury, subsequent acidification response induced by nigericin, thereby we have utilized continuously cultured tumor cells as model further supporting the notion of enhanced transmembrane ion targets. In previous studies (11, 12), K562 cells exposed to de- flow during exposure. These initial effects on the plasma mem- fensins began to release radiolabeled chromium after a lag pe- brane were not sufficient for subsequent lysis; a second phase of riod of 3-4 h. -
I M M U N O L O G Y Core Notes
II MM MM UU NN OO LL OO GG YY CCOORREE NNOOTTEESS MEDICAL IMMUNOLOGY 544 FALL 2011 Dr. George A. Gutman SCHOOL OF MEDICINE UNIVERSITY OF CALIFORNIA, IRVINE (Copyright) 2011 Regents of the University of California TABLE OF CONTENTS CHAPTER 1 INTRODUCTION...................................................................................... 3 CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS ..............................................9 CHAPTER 3 ANTIBODY STRUCTURE I..................................................................17 CHAPTER 4 ANTIBODY STRUCTURE II.................................................................23 CHAPTER 5 COMPLEMENT...................................................................................... 33 CHAPTER 6 ANTIBODY GENETICS, ISOTYPES, ALLOTYPES, IDIOTYPES.....45 CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION..................................................................53 CHAPTER 8 GENETIC BASIS OF ANTIBODY DIVERSITY...................................61 CHAPTER 9 IMMUNOGLOBULIN BIOSYNTHESIS ...............................................69 CHAPTER 10 BLOOD GROUPS: ABO AND Rh .........................................................77 CHAPTER 11 CELL-MEDIATED IMMUNITY AND MHC ........................................83 CHAPTER 12 CELL INTERACTIONS IN CELL MEDIATED IMMUNITY ..............91 CHAPTER 13 T-CELL/B-CELL COOPERATION IN HUMORAL IMMUNITY......105 CHAPTER 14 CELL SURFACE MARKERS OF T-CELLS, B-CELLS AND MACROPHAGES...............................................................111 -
1. Introduction to Immunology Professor Charles Bangham ([email protected])
MCD Immunology Alexandra Burke-Smith 1. Introduction to Immunology Professor Charles Bangham ([email protected]) 1. Explain the importance of immunology for human health. The immune system What happens when it goes wrong? persistent or fatal infections allergy autoimmune disease transplant rejection What is it for? To identify and eliminate harmful “non-self” microorganisms and harmful substances such as toxins, by distinguishing ‘self’ from ‘non-self’ proteins or by identifying ‘danger’ signals (e.g. from inflammation) The immune system has to strike a balance between clearing the pathogen and causing accidental damage to the host (immunopathology). Basic Principles The innate immune system works rapidly (within minutes) and has broad specificity The adaptive immune system takes longer (days) and has exisite specificity Generation Times and Evolution Bacteria- minutes Viruses- hours Host- years The pathogen replicates and hence evolves millions of times faster than the host, therefore the host relies on a flexible and rapid immune response Out most polymorphic (variable) genes, such as HLA and KIR, are those that control the immune system, and these have been selected for by infectious diseases 2. Outline the basic principles of immune responses and the timescales in which they occur. IFN: Interferon (innate immunity) NK: Natural Killer cells (innate immunity) CTL: Cytotoxic T lymphocytes (acquired immunity) 1 MCD Immunology Alexandra Burke-Smith Innate Immunity Acquired immunity Depends of pre-formed cells and molecules Depends on clonal selection, i.e. growth of T/B cells, release of antibodies selected for antigen specifity Fast (starts in mins/hrs) Slow (starts in days) Limited specifity- pathogen associated, i.e. -
Which Is Directly Mediated by Fumigatus Aspergillus Antifungal Activity Against Human NK Cells Display Importa
Human NK Cells Display Important Antifungal Activity against Aspergillus fumigatus , Which Is Directly Mediated by IFN- γ Release This information is current as of September 28, 2021. Maria Bouzani, Michael Ok, Allison McCormick, Frank Ebel, Oliver Kurzai, C. Oliver Morton, Hermann Einsele and Juergen Loeffler J Immunol 2011; 187:1369-1376; Prepublished online 22 June 2011; Downloaded from doi: 10.4049/jimmunol.1003593 http://www.jimmunol.org/content/187/3/1369 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2011/06/22/jimmunol.100359 Material 3.DC1 References This article cites 41 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/187/3/1369.full#ref-list-1 Why The JI? Submit online. by guest on September 28, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Human NK Cells Display Important Antifungal Activity against Aspergillus fumigatus, Which Is Directly Mediated by IFN-g Release Maria Bouzani,* Michael Ok,* Allison McCormick,† Frank Ebel,† Oliver Kurzai,‡,x C. -
The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth
The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth This information is current as Amanda S. Büchau, Shin Morizane, Janet Trowbridge, of September 27, 2021. Jürgen Schauber, Paul Kotol, Jack D. Bui and Richard L. Gallo J Immunol 2010; 184:369-378; Prepublished online 30 November 2009; doi: 10.4049/jimmunol.0902110 Downloaded from http://www.jimmunol.org/content/184/1/369 References This article cites 68 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/184/1/369.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 27, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth Amanda S. Bu¨chau,*,† Shin Morizane,*,† Janet Trowbridge,*,†,1 Ju¨rgen Schauber,*,†,‡ Paul Kotol,*,† Jack D.